ADPKD Guide
Readable, evidence-first ADPKD treatment, symptoms, diet, trials, and research updates for patients, families, and clinicians.
Methodology References Support GitHub
Patient Guide Treatment Trials Cure
More
Newly Diagnosed Tolvaptan Diet Symptoms Clinicians Methodology References Support
ADPKD Treatment Guide Treatment hierarchy

ADPKD treatment, what helps now, and what is still emerging

No clinically proven cure yet. Tolvaptan is still the strongest disease-modifying option in appropriate high-risk adults.

Last reviewed: April 25, 2026

Best-supported now

  • Tolvaptan in appropriate high-risk adults (Tier 1)
  • Risk-stratified intervention timing (imaging + eGFR trajectory) (Tier 1)
  • SGLT2 inhibitors in ADPKD (Tier 2 to Tier 3 signal)

Supportive care

  • Blood pressure management
  • Sodium reduction and CKD-aware daily habits
  • Risk-stratified follow-up and progression tracking
  • Structured care over anecdotal advice

Promising, not proven

  • SGLT2 inhibitors in ADPKD (Tier 2 to Tier 3 signal)
  • SGLT2 inhibitors in ADPKD (Tier 2 to Tier 3 signal)
  • Metabolic and ketogenic strategies (Tier 2 feasibility / Tier 3 efficacy)

How to read treatment news

  • Human outcome data beats mechanistic excitement.
  • Trial status updates are not efficacy evidence.
  • Preclinical and observational signals should stay clearly labeled.
  • Patient selection and monitoring quality matter a lot.